ラット・マウスモデル市場規模、シェア、動向分析レポート：モデル・サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

ラット・マウスモデル市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界のラット・マウスモデル市場は2030年までに35億8,000万米ドルに達すると予測され、2024年から2030年までのCAGRは9.0％で拡大すると予測されています。

ヒト化マウスやラットモデルは、機能的なヒト遺伝子、組織、細胞、臓器により、生物学的研究や医学的研究に使用されています。健康や臨床の場では、これらのマウスやラットのプロトタイプはヒトの免疫系を再現するために利用されます。さらに、ヒト化マウス・ラットプロトタイプは、基礎研究、高分子医薬品の安全性評価、ヒト特有の感染症のシミュレーション、免疫療法アプローチの有効性試験などにも使用されています。

免疫不全疾患、腫瘍、その他様々な希少疾患の同定にマウス・ラットプロトタイプを使用すること、ヘルスケア会社やバイオテクノロジー会社による研究開発活動の増加、マウス・ラットモデル研究に対する政府や民間部門からの継続的な資金提供や介入が、世界市場を牽引しています。さらに、動物モデル開発のための技術進歩が市場成長を促進すると予想されています。企業は、より優れたモデルを開発するために先進技術を採用しています。例えば、2023年10月、同業界の大手企業であるTaconic Biosciences社は、マウスモデルの開発と製造を促進できるExprssMODEL CRISPRプラットフォームを発表しました。このプラットフォームは、拡大繁殖のステップを不要にし、研究全体のタイムラインを最低3カ月短縮することができます。このような開発は、予測期間中の業界の成長を促進すると予想されます。

さらに、この業界で事業を展開する企業は、市場での地位を強化するために、提携、共同研究、買収、合併など、いくつかの取り組みを行っています。例えば、2023年4月、カスタム遺伝子改変ラット、マウス、ウサギモデルのプロバイダーであるingenious targeting laboratory社は、Shanghai Model Organisms Center（SMOC）と提携し、SMOCの検証済み既製マウスモデルを欧州と北米で販売することになった。このような提携により、動物モデルへのアクセスが向上し、今後数年間の市場成長を促進することが期待されます。

ラット・マウスモデル市場レポートハイライト

• モデルセグメントは、2023年に88.6%の収益シェアを占め、モデルおよびサービスセグメントを支配しました。
• サービス分野は、凍結保存、繁殖、バリデーション、表現型、飼育、再活性化など、多くのサービスの提供に業界参加者がますます注力しているため、予測期間中に最も速いCAGRで成長すると予想されます。
• 用途別では、がん分野が2023年の市場を独占しました。一方、遺伝病セグメントは予測期間中に最も速い成長が期待されています。
• 北米地域は、Inotiv、Charles River Laboratories、Ozgene Pty Ltd、Taconic Biosciencesのような主要市場プレイヤーの存在や、同地域の製薬・研究分野の成長などの要因により、市場を独占しています。
• アジア太平洋地域は、日本のようなアジア太平洋諸国でのプレゼンスを拡大する企業が複数存在するため、予測期間中に最も速い成長を記録すると予想されます。
• 世界のラット・マウスモデル市場で事業を展開している主な市場プレイヤーには、Charles River Laboratories社、The Jackson Laboratory社、Cyagen社、genOway社、Inotiv社、Janvier Labs社、Taconic Biosciences社、Biomedical Research Models社（Biomere社）、Hera Biolabs社、Kind Lab社、Ozgene Pty Ltd社などがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ラット・マウスモデルの市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ラット・マウスモデル市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19感染症の影響分析

第4章 ラット・マウスモデル市場：モデル・サービスの推定・動向分析

• モデル・サービスの市場シェア、2023年と2030年
• セグメントダッシュボード
• モデル・サービス別の世界のラット・マウスモデル市場の見通し
• 以下のモデル・サービスの市場規模と予測および動向分析、2018年から2030年まで
  • モデル
  • サービス

第5章 ラット・マウスモデル市場：用途の推定・動向分析

• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別の世界のラット・マウスモデル市場の見通し
• 以下の用途市場規模、予測および動向分析、2018年から2030年まで
  • 2018年から2030年の用途市場推計・予測
  • 心血管疾患
  • 遺伝病
  • がん
  • 感染症
  • 移植
  • その他

第6章 ラット・マウスモデル市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別の世界のラット・マウスモデル市場の見通し
• 以下の最終用途市場規模、予測および動向分析、2018年から2030年まで
  • 製薬およびバイオテクノロジー企業
  • 学術研究施設
  • 受託研究および製造組織

第7章 ラット・マウスモデル市場：地域の推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測動向分析、2018年から2030年まで
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • 主要ディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業シェア分析、2023年
  • Charles River Laboratories
  • The Jackson Laboratory
  • Cyagen
  • genOway
  • Inotiv
  • Janvier Labs
  • Taconic Biosciences, Inc.
  • Biomedical Research Models（Biomere）
  • Hera Biolabs
  • Kind Lab
  • Ozgene Pty Ltd

List of Tables

• Table 1 List of abbreviations
• Table 2 North America rat and mouse model market, by region, 2018 - 2030 (USD Million)
• Table 3 North America rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 4 North America rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 5 North America rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 6 U.S. rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 7 U.S. rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 8 U.S. rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 9 Canada rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 10 Canada rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 11 Canada rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 12 Europe rat and mouse model market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 14 Europe rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 15 Europe rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 16 Germany rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 17 Germany rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 18 Germany rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 19 UK rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 20 UK rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 21 UK rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 22 France rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 23 France rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 24 France rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 25 Italy rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 26 Italy rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Italy rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 28 Spain rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 29 Spain rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 30 Spain rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 31 Denmark rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 32 Denmark rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Denmark rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 34 Sweden rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 35 Sweden rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Sweden rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 37 Norway rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 38 Norway rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Norway rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific rat and mouse model market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 44 China rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 45 China rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 46 China rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 47 Japan rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 48 Japan rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Japan rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 50 India rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 51 India rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 52 India rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 53 South Korea rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 54 South Korea rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 55 South Korea rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 56 Australia rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 57 Australia rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 58 Australia rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 59 Thailand rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 60 Thailand rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Thailand rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 62 Latin America rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 63 Latin America rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Latin America rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Brazil rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 67 Brazil rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 68 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
• Table 69 Mexico rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 70 Mexico rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 71 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
• Table 72 Argentina rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 73 Argentina rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 74 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
• Table 75 MEA rat and mouse model market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 77 MEA rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 78 MEA rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 79 South Africa rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 80 South Africa rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 81 South Africa rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 85 UAE rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 86 UAE rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 87 UAE rat and mouse model market, by application, 2018 - 2030 (USD Million)
• Table 88 Kuwait rat and mouse model market, by model and service, 2018 - 2030 (USD Million)
• Table 89 Kuwait rat and mouse model market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Kuwait rat and mouse model market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Rat and mouse model market: market outlook
• Fig. 14 Rat and mouse model competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Rat and mouse model market driver impact
• Fig. 20 Rat and mouse model market restraint impact
• Fig. 21 Rat and mouse model market strategic initiatives analysis
• Fig. 22 Rat and mouse model market: model and service movement analysis
• Fig. 23 Rat and mouse model market: model and service outlook and key takeaways
• Fig. 24 Model market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Inbred market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Knockout market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Knock-ins market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Outbred market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Knockout market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Knock-ins market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Service market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Cryopreservation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Breeding market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Rederivation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Quarantine depending market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Rat and mouse model Market: Application movement Analysis
• Fig. 41 Rat and mouse model market: Application outlook and key takeaways
• Fig. 42 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Genetic diseases market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 44 Cancer market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 45 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 COVID 19-market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 47 Others market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 48 Transplantation market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 49 Other diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Rat and mouse model market: end-use movement analysis
• Fig. 51 Rat and mouse model market: end-use outlook and key takeaways
• Fig. 52 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Academic and research facilities market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 54 Contract research & manufacturing organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 North America rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 U.S. rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Canada rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Europe rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 UK rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Germany rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 France rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Italy rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Spain rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Denmark rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Sweden rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Norway rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Asia Pacific rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 China rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Japan rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 India rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Thailand rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 South Korea rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Australia rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Latin America rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Brazil rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Mexico rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Argentina rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Middle East and Africa rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 South Africa rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Saudi Arabia rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 UAE rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Kuwait rat and mouse model market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Market share of key market players- Rat and mouse model market

Rat And Mouse Model Market Growth & Trends:

The global rat and mouse model market is anticipated to reach USD 3.58 billion by 2030 and is anticipated to expand at a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Humanized mouse and rat models are used in biological and medical research due to functional human genes, tissues, cells, and organs. In health and clinical settings, these mouse & rat prototypes are utilized to replicate the human immune system. Furthermore, humanized mouse and rat prototypes are used for basic research, evaluating the safety of large-molecule medicines, simulating some human-specific infectious diseases, along with testing the efficacy of immunotherapy approaches.

The use of mouse & rat prototypes for the identification of immunodeficiency disorders, tumors, and various other rare diseases, along with an increase in R&D activities carried out by healthcare and biotechnology companies, as well as continuous funding and interventions from governments and private sectors for mouse & rat model research, are driving the global market. Furthermore, technological advancements for developing animal models are anticipated to spur market growth. Companies are adopting advanced technologies to develop better models. For instance, in October 2023, Taconic Biosciences, a major company operating in the industry, announced the ExprssMODEL CRISPR Platform, which can advance the development and manufacturing of mouse models. This platform can eliminate the need for an expansion breeding step and saves a minimum three months in the overall study timeline. Such developments are anticipated to drive the industry's growth over the forecast period.

Furthermore, players operating in the industry are undertaking several initiatives like partnerships, collaborations, acquisitions, and mergers to strengthen their market position. For instance, in April 2023, an ingenious targeting laboratory, a provider of custom genetically modified rat, mouse, and rabbit models, partnered with Shanghai Model Organisms Center (SMOC) to distribute SMOC's validated off-the-shelf mouse models in Europe and North America. Such collaborations are expected to increase the accessibility of animal models, which can drive market growth in the coming years.

Rat And Mouse Model Market Report Highlights:

• The models segment dominated the model and service segment with a revenue share of 88.6% in 2023, owing to the availability of different types of rats and animal models.
• The services segment is expected to grow at the fastest CAGR over the forecast period due to the increasing focus of industry participants on offering numerous services like cryopreservation, breeding, validation, phenotyping, husbandry and rederivation, among others.
• Based on application, the cancer segment dominated the market in 2023. On the other hand, the genetic diseases segment is expected to witness the fastest growth over the forecast period.
• North America region dominated the market owing to factors such as the presence of key market players like Inotiv, Charles River Laboratories, Ozgene Pty Ltd, Taconic Biosciences and the growth in pharmaceutical as well as research sectors in this region.
• Asia Pacific is expected to register the fastest growth over the forecast period due to several companies expanding their presence in Asia Pacific countries like Japan.
• Major market players operating in the global rat and mouse models market include Charles River Laboratories, The Jackson Laboratory, Cyagen, genOway, Inotiv, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Hera Biolabs, Kind Lab, and Ozgene Pty Ltd. among others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Model and Service
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for Primary Interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for Primary Interviews in Latin America
    • 1.4.5.5. Data for Primary Interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Model and Service Outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Rat and Mouse Model Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rise in adoption of personalized & precision medicine and increasing demand of rat & mouse models.
    • 3.2.1.2. Application of genome editing tools for generation of rodent models
    • 3.2.1.3. Increase in the number of research activities involving the use of rat and mouse models.
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical issues pertaining to the use of animals for research.
    • 3.2.2.2. Rise in adoption of alternative animal models for biomedical research
• 3.3. Rat and Mouse Model Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic Landscape
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Rat and Mouse Model Market: Model and Service Estimates & Trend Analysis

• 4.1. Model and Service Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Rat and Mouse Model Market by Model and Service Outlook
• 4.4. Model & Service Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
  • 4.4.1. Model
    • 4.4.1.1. Model Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Inbred
    • 4.4.1.2.1. Inbred Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2.2. Knockout
    • 4.4.1.2.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2.3. Knock-in
    • 4.4.1.2.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2.4. Others
    • 4.4.1.2.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Outbred
    • 4.4.1.3.1. Outbred Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.2. Knockout
    • 4.4.1.3.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.3. Knock-in
    • 4.4.1.3.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.4. Others
    • 4.4.1.3.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Service
    • 4.4.2.1. Service Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Cryopreservation
    • 4.4.2.2.1. Cryopreservation Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Breeding
    • 4.4.2.3.1. Breeding Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Rederivation
    • 4.4.2.4.1. Rederivation Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.5. Genetic Testing
    • 4.4.2.5.1. Genetic Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.6. Quarantine Depending
    • 4.4.2.6.1. Quarantine Depending Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.7. Others
    • 4.4.2.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rat and Mouse Model Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Rat and Mouse Model Market by Application Outlook
• 5.4. Application Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
  • 5.4.1. Application Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Cardiovascular diseases
    • 5.4.2.1. Cardiovascular Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Genetic Diseases
    • 5.4.3.1. Genetic Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Cancer
    • 5.4.4.1. Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Infectious Diseases
    • 5.4.5.1. Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5.1.1. COVID-19
    • 5.4.5.1.1.1. COVID-19 Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5.1.2. Others
    • 5.4.5.1.2.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Transplantation
    • 5.4.6.1. Transplantation Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Others
    • 5.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rat and Mouse Model Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Rat and Mouse Model Market by End-use Outlook
• 6.4. End-use Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
  • 6.4.1. Pharmaceutical & Biotechnology companies
    • 6.4.1.1. Pharmaceutical & Biotechnology Companies Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Academic and Research Facilities
    • 6.4.2.1. Academic and Research Facilities Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Contract Research & Manufacturing Organizations
    • 6.4.3.1. Contract Research & Manufacturing Organizations Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rat and Mouse Model Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Charles River Laboratories
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. The Jackson Laboratory
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Cyagen
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. genOway
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Inotiv
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Janvier Labs
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Taconic Biosciences, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Biomedical Research Models (Biomere)
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Hera Biolabs
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Kind Lab
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Ozgene Pty Ltd
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives